Mechanism of resistance to chemotherapy in triple negative breast cancer

被引：0
|
作者：
Loi, S. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30064-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 2.4
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [31] Pembrolizumab plus Chemotherapy for triple-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1114 - 1114
  • [32] Triple negative breast cancer: adjuvant chemotherapy effect on survival
    Steponaviciene, L.
    Lachej-Mikeroviene, N.
    Smailyte, G.
    Aleknavicius, E.
    Meskauskas, R.
    Didziapetriene, J.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 285 - 290
  • [33] Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
    Mayer, Erica L.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3369 - +
  • [34] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [35] Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
    Shao, Zhiying
    Chaudhri, Shalini
    Guo, Meng
    Zhang, Longzhen
    Rea, Daniel
    ONCOLOGY RESEARCH, 2016, 23 (06) : 291 - 302
  • [36] Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
    Aldrich, Jeffrey
    Canning, Madison
    Bhave, Manali
    CLINICAL BREAST CANCER, 2023, 23 (08) : 832 - 834
  • [37] Neoadjuvant chemotherapy regimens for triple negative breast cancer patients
    Gigolaeva, L.
    Krivorotko, P.
    Zhiltsova, E.
    Dashyan, G.
    Chadjimatova, S.
    Pesotckiy, R.
    Emelyanov, A.
    Semiglazov, V.
    BREAST, 2019, 44 : S70 - S70
  • [38] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [39] Potential chemotherapy options in the triple negative subtype of breast cancer
    Altundag, Kadri
    Harputluoglu, Hakan
    Aksoy, Sercan
    Gullu, Ibrahim H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1294 - 1295
  • [40] Platinum-based chemotherapy in triple negative breast cancer
    Eckstein, N.
    Haas, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (07) : 333 - 336
12345